• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板减少症与早产儿视网膜病变的相关性研究

THROMBOCYTOPENIA AS A RISK FACTOR FOR RETINOPATHY OF PREMATURITY.

机构信息

Neonatal Intensive Care Unit, Zeynep Kamil Maternity and Children's Training and Research Hospital, Istanbul, TR.

Neonatal Intensive Care Unit, Medeniyet University, Istanbul, TR.

出版信息

Retina. 2019 Apr;39(4):706-711. doi: 10.1097/IAE.0000000000002028.

DOI:10.1097/IAE.0000000000002028
PMID:29370028
Abstract

PURPOSE

To study the association between thrombocytopenia and retinopathy of prematurity (ROP).

METHODS

The case-control study was conducted on preterm newborns with ROP between January 2011 and January 2014, retrospectively. The patients were assigned into two groups: Cases required intervention and controls developed no or Stage I ROP.

RESULTS

Eighty-one premature infants with Type I ROP were enrolled to the study with a mean gestational age of 27.6 ± 2.1 (range: 24-32) weeks and birth weight of 993 ± 292 (range: 560-1,930) g. Mean follow-up time was 38.3 ± 2.7 weeks (min: 32 and max: 46 weeks). Cases were individually matched to a set of controls (1:1 ratio). Thrombocytopenia (<150.000/mm) was seen in 58 (71.6%) of the cases with Type I ROP, whereas only 17 (21%) of the controls had thrombocytopenia (P < 0.001). Logistic regression analysis showed that bronchopulmonary dysplasia and thrombocytopenia were significantly associated with Type I ROP (relative risk [95% confidence interval]: 4.19 [1.47-12] and 6.69 [2.83-15.9], respectively). The thrombocytopenia ratio (P = 0.073), thrombocytopenia 1 week before intervention (P = 0.076) and platelet transfusion ratio (P = 0.062) tended to be higher in Zone I ROP compared with Zone II ROP.

CONCLUSION

In our study, there was a significant association between thrombocytopenia and Type I ROP.

摘要

目的

研究血小板减少症与早产儿视网膜病变(ROP)的关系。

方法

采用回顾性病例对照研究,选取 2011 年 1 月至 2014 年 1 月间收治的患有 ROP 的早产儿,将其分为两组:病例组需要干预治疗,对照组为无或 I 期 ROP。

结果

共纳入 81 例 I 型 ROP 早产儿,平均胎龄为 27.6±2.1(范围:24-32)周,出生体重为 993±292(范围:560-1930)g。平均随访时间为 38.3±2.7 周(最短 32 周,最长 46 周)。每个病例组患儿均与一组对照组患儿(1:1 比例)进行配对。在 I 型 ROP 患儿中,58 例(71.6%)存在血小板减少症(血小板计数<150.000/mm),而对照组中只有 17 例(21%)存在血小板减少症(P<0.001)。Logistic 回归分析显示,支气管肺发育不良和血小板减少症与 I 型 ROP 显著相关(相对危险度[95%置信区间]:4.19[1.47-12]和 6.69[2.83-15.9])。与 II 区 ROP 相比,I 区 ROP 血小板减少症比例(P=0.073)、干预前 1 周血小板减少症(P=0.076)和血小板输注比例(P=0.062)较高。

结论

在本研究中,血小板减少症与 I 型 ROP 之间存在显著关联。

相似文献

1
THROMBOCYTOPENIA AS A RISK FACTOR FOR RETINOPATHY OF PREMATURITY.血小板减少症与早产儿视网膜病变的相关性研究
Retina. 2019 Apr;39(4):706-711. doi: 10.1097/IAE.0000000000002028.
2
RATES AND RISK FACTORS FOR RECURRENCE OF RETINOPATHY OF PREMATURITY AFTER LASER OR INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR MONOTHERAPY.早产儿视网膜病变激光或玻璃体腔内抗血管内皮生长因子单药治疗后复发的发生率及危险因素。
Retina. 2020 Sep;40(9):1793-1803. doi: 10.1097/IAE.0000000000002663.
3
Efficacy of intravitreal bevacizumab for zone-II retinopathy of prematurity.玻璃体内注射贝伐单抗治疗Ⅱ区早产儿视网膜病变的疗效
Acta Ophthalmol. 2016 Sep;94(6):e417-20. doi: 10.1111/aos.13008. Epub 2016 Mar 24.
4
Outcomes after Intravitreal Bevacizumab versus Laser Photocoagulation for Retinopathy of Prematurity: A 5-Year Retrospective Analysis.玻璃体腔注射贝伐单抗与激光光凝治疗早产儿视网膜病变的5年回顾性分析结果
Ophthalmology. 2015 May;122(5):1008-15. doi: 10.1016/j.ophtha.2014.12.017. Epub 2015 Feb 14.
5
[Epidemiology and treatment of retinopathy of prematurity. The Hannover data in the Retina.net ROP registry from 2001-2017].早产儿视网膜病变的流行病学与治疗。2001年至2017年视网膜网ROP登记处的汉诺威数据
Ophthalmologe. 2022 May;119(5):497-505. doi: 10.1007/s00347-021-01528-9. Epub 2021 Nov 22.
6
Efficacy of supplemental oxygen in reducing the need for laser or intravitreal bevacizumab in preterm infants with stage 2 retinopathy of prematurity.补充氧气在减少早产儿 2 期早产儿视网膜病变激光或玻璃体内贝伐单抗治疗需求中的疗效。
BMC Ophthalmol. 2024 May 24;24(1):220. doi: 10.1186/s12886-024-03483-w.
7
Intravitreal Bevacizumab for Zone II Retinopathy of Prematurity.玻璃体内注射贝伐单抗治疗Ⅱ区早产儿视网膜病变
J Pediatr Ophthalmol Strabismus. 2016 Nov 1;53(6):375-382. doi: 10.3928/01913913-20160727-01. Epub 2016 Aug 18.
8
ANALYSIS OF CHANGES IN CHARACTERISTICS OF SEVERE RETINOPATHY OF PREMATURITY PATIENTS AFTER SCREENING GUIDELINES WERE ISSUED IN CHINA.中国发布筛查指南后早产儿视网膜病变严重程度特征变化分析
Retina. 2015 Aug;35(8):1674-9. doi: 10.1097/IAE.0000000000000512.
9
Refractive outcome of intravitreal bevacizumab injection in comparison to spontaneous regression of retinopathy of prematurity (ROP).玻璃体内注射贝伐单抗与早产儿视网膜病变(ROP)自然消退相比的屈光结果。
Strabismus. 2020 Mar;28(1):49-54. doi: 10.1080/09273972.2019.1697302. Epub 2019 Dec 2.
10
Comparison of Bevacizumab, Ranibizumab, and Laser Photocoagulation in the Treatment of Retinopathy of Prematurity in Turkey.贝伐单抗、雷珠单抗和激光光凝治疗土耳其早产儿视网膜病变的比较。
Curr Eye Res. 2017 Mar;42(3):462-469. doi: 10.1080/02713683.2016.1196709. Epub 2016 Jul 15.

引用本文的文献

1
Platelet Counts and Risk of Severe Retinopathy of Prematurity: A Bayesian Model-Averaged Meta-Analysis.血小板计数与早产儿严重视网膜病变风险:一项贝叶斯模型平均荟萃分析
Children (Basel). 2023 Dec 8;10(12):1903. doi: 10.3390/children10121903.
2
A novel marker for predicting type 1 retinopathy of prematurity: C-reactive protein/albumin ratio.一种预测早产儿 1 型视网膜病变的新型标志物:C 反应蛋白/白蛋白比值。
Int Ophthalmol. 2023 Sep;43(9):3345-3353. doi: 10.1007/s10792-023-02740-z. Epub 2023 Jun 6.
3
The Role of Thrombocyte Parameters in Retinopathy of Prematurity Development.
血小板参数在早产儿视网膜病变发展中的作用。
Int J Clin Pract. 2022 Jan 31;2022:7518533. doi: 10.1155/2022/7518533. eCollection 2022.
4
Platelet is the early predictor of bronchopulmonary dysplasia in very premature infants: an observational cohort study.血小板是极早产儿支气管肺发育不良的早期预测指标:一项观察性队列研究。
BMC Pulm Med. 2022 Mar 27;22(1):109. doi: 10.1186/s12890-022-01895-2.
5
The association of platelet counts with development and treatment for retinopathy of prematurity - is thrombocytopenia a risk factor?血小板计数与早产儿视网膜病变的发生及治疗的关联——血小板减少症是一个危险因素吗?
Arch Med Sci. 2019 May 27;18(2):400-405. doi: 10.5114/aoms.2019.85386. eCollection 2022.
6
Thrombocytopenia as Type 1 ROP Biomarker: A Longitudinal Study.血小板减少症作为1型视网膜病变的生物标志物:一项纵向研究。
J Pers Med. 2021 Oct 30;11(11):1120. doi: 10.3390/jpm11111120.
7
Comparison of Mean Platelet Counts in Preterm Infants with and without Retinopathy of Prematurity.早产儿有无早产儿视网膜病变时血小板平均计数的比较。
Int J Environ Res Public Health. 2021 Apr 5;18(7):3783. doi: 10.3390/ijerph18073783.
8
Decreased Platelet Counts and Serum Levels of VEGF-A, PDGF-BB, and BDNF in Extremely Preterm Infants Developing Severe ROP.极低出生体重早产儿发生重度 ROP 时血小板计数和血清 VEGF-A、PDGF-BB、BDNF 水平降低。
Neonatology. 2021;118(1):18-27. doi: 10.1159/000512282. Epub 2021 Feb 19.
9
Severe retinopathy of prematurity is associated with early post-natal low platelet count.严重早产儿视网膜病变与出生后早期血小板计数低有关。
Sci Rep. 2021 Jan 13;11(1):891. doi: 10.1038/s41598-020-79535-0.
10
Associations between Red Blood Cell and Platelet Transfusions and Retinopathy of Prematurity.红细胞和血小板输注与早产儿视网膜病变之间的关联。
Neonatology. 2020 Dec 8;117(5):1-7. doi: 10.1159/000512020.